Exclusive: Onyx provides drug trial data to potential bidders - sources

NEW YORK (Reuters) - Onyx Pharmaceuticals Inc has given potential buyers, including Amgen Inc, access to trial data on its new cancer drug, removing a key hurdle that was holding up deal talks, according to three people familiar with the matter. The company's attempt to sell itself for around $9.5 billion hit an impasse in recent weeks after lead bidder Amgen sought trial data about blood cancer drug Kyprolis - something that Onyx was reluctant to share, Reuters reported last week. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/exclusive-onyx-provides-drug-trial-data-potential-bidders-213448933.html